Cargando…

Clinical application of a novel stent-assisted in situ intestinal bypass in preventing postoperative anastomotic leakage for low-mid rectal cancer: A retrospective study

This study aimed to investigate the safety and feasibility of a novel stent-assisted in situ intestinal bypass for low-mid rectal cancer patients. Patients who were diagnosed with rectal cancer and received laparoscopic low anterior rectal resection plus a novel stent-assisted in situ intestinal byp...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Xiong, Bai, Lian, Li, Qi-Gang, Xie, Jian, Liu, Chang-An, Wen, Ze-Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627669/
https://www.ncbi.nlm.nih.gov/pubmed/37933042
http://dx.doi.org/10.1097/MD.0000000000035756
_version_ 1785131571767934976
author Zhou, Xiong
Bai, Lian
Li, Qi-Gang
Xie, Jian
Liu, Chang-An
Wen, Ze-Lin
author_facet Zhou, Xiong
Bai, Lian
Li, Qi-Gang
Xie, Jian
Liu, Chang-An
Wen, Ze-Lin
author_sort Zhou, Xiong
collection PubMed
description This study aimed to investigate the safety and feasibility of a novel stent-assisted in situ intestinal bypass for low-mid rectal cancer patients. Patients who were diagnosed with rectal cancer and received laparoscopic low anterior rectal resection plus a novel stent-assisted in situ intestinal bypass were respectively included from March 2022 to June 2022. Biofragmentable intestinal stent with a protective sleeve was placed in the proximal colon before anastomosis, and feces could be discharged through the protective sleeve without touching the anastomosis, which achieved an in situ bypass of feces. Perioperative characteristics and short-term outcomes were collected. Rectal imaging was performed each week after surgery for the first 3 weeks to surveil the stent and feces delivery. Follow-ups were conducted for more than 3 months. Thirty patients who successfully received surgery were included in this study. There were 18 (60.0%) males and 12 (40.0%) females. As for perioperative characteristics, operation time was 213.8 ± 43.0 minutes, blood loss was 53.3 ± 24.6 mL, time to first flatus via protective sleeve after surgery was 3.2 ± 1.1 days, postoperative hospital stay was 11.8 ± 1.6 days, and time to discharge stent was 22.4 ± 3.2 days. As for short-term outcomes, 6 patients suffered from pneumonia, urinary tract infection or incision infection. During the follow-up, there was no anastomotic leakage or mortality. This novel stent-assisted in situ intestinal bypass is safe and feasible, it might be an applicable way to prevent postoperative anastomotic leakage for patients with low-mid rectal cancer.
format Online
Article
Text
id pubmed-10627669
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-106276692023-11-07 Clinical application of a novel stent-assisted in situ intestinal bypass in preventing postoperative anastomotic leakage for low-mid rectal cancer: A retrospective study Zhou, Xiong Bai, Lian Li, Qi-Gang Xie, Jian Liu, Chang-An Wen, Ze-Lin Medicine (Baltimore) 5700 This study aimed to investigate the safety and feasibility of a novel stent-assisted in situ intestinal bypass for low-mid rectal cancer patients. Patients who were diagnosed with rectal cancer and received laparoscopic low anterior rectal resection plus a novel stent-assisted in situ intestinal bypass were respectively included from March 2022 to June 2022. Biofragmentable intestinal stent with a protective sleeve was placed in the proximal colon before anastomosis, and feces could be discharged through the protective sleeve without touching the anastomosis, which achieved an in situ bypass of feces. Perioperative characteristics and short-term outcomes were collected. Rectal imaging was performed each week after surgery for the first 3 weeks to surveil the stent and feces delivery. Follow-ups were conducted for more than 3 months. Thirty patients who successfully received surgery were included in this study. There were 18 (60.0%) males and 12 (40.0%) females. As for perioperative characteristics, operation time was 213.8 ± 43.0 minutes, blood loss was 53.3 ± 24.6 mL, time to first flatus via protective sleeve after surgery was 3.2 ± 1.1 days, postoperative hospital stay was 11.8 ± 1.6 days, and time to discharge stent was 22.4 ± 3.2 days. As for short-term outcomes, 6 patients suffered from pneumonia, urinary tract infection or incision infection. During the follow-up, there was no anastomotic leakage or mortality. This novel stent-assisted in situ intestinal bypass is safe and feasible, it might be an applicable way to prevent postoperative anastomotic leakage for patients with low-mid rectal cancer. Lippincott Williams & Wilkins 2023-11-03 /pmc/articles/PMC10627669/ /pubmed/37933042 http://dx.doi.org/10.1097/MD.0000000000035756 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC) (https://creativecommons.org/licenses/by-nc/4.0/) , where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal.
spellingShingle 5700
Zhou, Xiong
Bai, Lian
Li, Qi-Gang
Xie, Jian
Liu, Chang-An
Wen, Ze-Lin
Clinical application of a novel stent-assisted in situ intestinal bypass in preventing postoperative anastomotic leakage for low-mid rectal cancer: A retrospective study
title Clinical application of a novel stent-assisted in situ intestinal bypass in preventing postoperative anastomotic leakage for low-mid rectal cancer: A retrospective study
title_full Clinical application of a novel stent-assisted in situ intestinal bypass in preventing postoperative anastomotic leakage for low-mid rectal cancer: A retrospective study
title_fullStr Clinical application of a novel stent-assisted in situ intestinal bypass in preventing postoperative anastomotic leakage for low-mid rectal cancer: A retrospective study
title_full_unstemmed Clinical application of a novel stent-assisted in situ intestinal bypass in preventing postoperative anastomotic leakage for low-mid rectal cancer: A retrospective study
title_short Clinical application of a novel stent-assisted in situ intestinal bypass in preventing postoperative anastomotic leakage for low-mid rectal cancer: A retrospective study
title_sort clinical application of a novel stent-assisted in situ intestinal bypass in preventing postoperative anastomotic leakage for low-mid rectal cancer: a retrospective study
topic 5700
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627669/
https://www.ncbi.nlm.nih.gov/pubmed/37933042
http://dx.doi.org/10.1097/MD.0000000000035756
work_keys_str_mv AT zhouxiong clinicalapplicationofanovelstentassistedinsituintestinalbypassinpreventingpostoperativeanastomoticleakageforlowmidrectalcanceraretrospectivestudy
AT bailian clinicalapplicationofanovelstentassistedinsituintestinalbypassinpreventingpostoperativeanastomoticleakageforlowmidrectalcanceraretrospectivestudy
AT liqigang clinicalapplicationofanovelstentassistedinsituintestinalbypassinpreventingpostoperativeanastomoticleakageforlowmidrectalcanceraretrospectivestudy
AT xiejian clinicalapplicationofanovelstentassistedinsituintestinalbypassinpreventingpostoperativeanastomoticleakageforlowmidrectalcanceraretrospectivestudy
AT liuchangan clinicalapplicationofanovelstentassistedinsituintestinalbypassinpreventingpostoperativeanastomoticleakageforlowmidrectalcanceraretrospectivestudy
AT wenzelin clinicalapplicationofanovelstentassistedinsituintestinalbypassinpreventingpostoperativeanastomoticleakageforlowmidrectalcanceraretrospectivestudy